Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Issued
Ratios

Champions Oncology (CSBR) Receivables - Net (2016 - 2026)

Champions Oncology has reported Receivables - Net over the past 16 years, most recently at $12.1 million for Q1 2026.

  • Quarterly results put Receivables - Net at $12.1 million for Q1 2026, down 23.54% from a year ago — trailing twelve months through Jan 2026 was $12.1 million (down 23.54% YoY), and the annual figure for FY2025 was $11.2 million, up 17.61%.
  • Receivables - Net for Q1 2026 was $12.1 million at Champions Oncology, up from $11.5 million in the prior quarter.
  • Over the last five years, Receivables - Net for CSBR hit a ceiling of $15.8 million in Q1 2025 and a floor of $4.7 million in Q3 2024.
  • Median Receivables - Net over the past 5 years was $9.4 million (2022), compared with a mean of $9.6 million.
  • Biggest five-year swings in Receivables - Net: crashed 47.53% in 2024 and later surged 100.64% in 2025.
  • Champions Oncology's Receivables - Net stood at $9.0 million in 2022, then fell by 14.44% to $7.7 million in 2023, then soared by 49.23% to $11.5 million in 2024, then increased by 0.42% to $11.5 million in 2025, then grew by 4.58% to $12.1 million in 2026.
  • The last three reported values for Receivables - Net were $12.1 million (Q1 2026), $11.5 million (Q4 2025), and $9.5 million (Q3 2025) per Business Quant data.